Evaluating how self-efficacy affects CPAP compliance in patients with obstructive sleep apnea
Evaluation of Self-efficacy as a Predictor for CPAP-compliance in a OSAS-patients French Cohort
This study looks at how a person's confidence in managing their condition affects their use of CPAP therapy in people newly diagnosed with obstructive sleep apnea.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 150 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | University Hospital, Bordeaux Academic / other |
| Locations | 1 site (Bordeaux) |
| Trial ID | NCT05053581 on ClinicalTrials.gov |
What this trial studies
This observational study aims to assess the role of self-efficacy as a predictor of compliance with continuous positive airway pressure (CPAP) therapy in patients newly diagnosed with obstructive sleep apnea syndrome (OSAS). Researchers will recruit 150 patients and collect data through four questionnaires that evaluate demographic factors, sleep complaints, self-efficacy, and nasal respiratory issues. The study will track CPAP usage over the first month and at 3 and 6 months post-treatment initiation. The goal is to identify key factors influencing adherence to CPAP therapy, particularly focusing on self-efficacy.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 to 65 with a new diagnosis of obstructive sleep apnea requiring CPAP treatment.
Not a fit: Patients with current psychiatric or neurological disorders, uncontrolled cardiovascular or respiratory issues, or those who are pregnant or breastfeeding may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved adherence to CPAP therapy, enhancing the quality of life for patients with obstructive sleep apnea.
How similar studies have performed: Previous studies have indicated that self-efficacy is a significant factor in treatment adherence, suggesting that this approach may yield valuable insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients with new OSAS-diagnosed (Apnea-Hypopnea Index≥ 15) with CPAP as intended treatment * Patients agreeing follow-up by telemonitoring * Age between 18 and 65 years * Affiliated person or beneficiary of a social security scheme * Informed and expressed his/her non-opposition to engage in the study Exclusion Criteria: * Night-workers or shift-workers * Current psychiatric disorder (mood disorders, anxiety disorders, psychosis, dependence interfering with nocturnal sleep) assessed by the investigator during medical interview * Current neurologic disorders interfering with sleep (for example: neurodegeneratives diseases, stroke, epilepsy) assessed by the investigator during medical interview * Uncontrolled cardiovascular or respiratory disorders * Pregnant women or breastfeeding mother. * Person under guardianship or curatorship
Where this trial is running
Bordeaux
- CHU de Bordeaux — Bordeaux, France (Recruiting)
Study contacts
- Study coordinator: Jean-Arthur MICOULAUD-FRANCHI, MD, PhD
- Email: jarthur.micoulaud@gmail.com
- Phone: 05 56 79 56 79
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.